CLSI M24 A2 : 2ED 2011
Withdrawn
A Withdrawn Standard is one, which is removed from sale, and its unique number can no longer be used. The Standard can be withdrawn and not replaced, or it can be withdrawn and replaced by a Standard with a different number.
SUSCEPTIBILITY TESTING OF MYCOBACTERIA, NOCARDIAE, AND OTHER AEROBIC ACTINOMYCETES
11-28-2018
11-28-2018
Abstract
Committee Membership
Foreword
1 Scope
2 Standard Precautions
3 Terminology
4 Antimycobacterial Susceptibility for Mycobacterium
tuberculosis Complex
5 Susceptibility Testing of Nontuberculous Mycobacteria
6 Susceptibility Testing of Aerobic Actinomycetes
References
Appendix A - Susceptibility Testing of Mycobacterium
tuberculosis Complex to Second-line Drugs
Using Commercial Shorter Incubation
Liquid Media Systems
Appendix B - Suggested Approach to Mycobacterium
tuberculosis Complex Susceptibility
Testing in Resource-Limited Countries
Appendix C - Example Illustrating Drug Calculation for
Meropenum Trihydrate
Appendix D - Preparation and Plating of 7H10 and 7H11
Agar Medium
Appendix E - Preparation of Media With Drug-Containing Disks
Appendix F - Preparing 7H10/H11 Agar With Liquid Drug
Appendix G - McFarland 0.5 Barium Sulfate Turbidity Standard
Appendix H - Determining Percentage of Resistance
Appendix I - Drugs Available for Susceptibility Testing
of Mycobacterium tuberculosis Complex
Using Commercial Shorter Incubation Liquid
Media Systems Cleared for Use by the US Food
and Drug Administration and Their Equivalence
in the Agar Proportion Method
Appendix J - Agar Disk Elution Method for Mycobacterium
haemophilum
Appendix K - Expected Antimicrobial Susceptibility Patterns
of the Most Commonly Isolated Nocardia
The Quality Management System Approach
Related CLSI Reference Materials
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.